- Home
- HROW vs BY Comparison
HROW vs BY Comparison
Compare HROW & BY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HROW
- BY
- Stock Information
- Founded
- HROW 1998
- BY 1914
- Country
- HROW United States
- BY United States
- Employees
- HROW N/A
- BY N/A
- Industry
- HROW Biotechnology: Pharmaceutical Preparations
- BY Major Banks
- Sector
- HROW Health Care
- BY Finance
- Exchange
- HROW Nasdaq
- BY Nasdaq
- Market Cap
- HROW 1.4B
- BY 1.2B
- IPO Year
- HROW N/A
- BY 2017
- Fundamental
- Price
- HROW $33.71
- BY $27.20
- Analyst Decision
- HROW Strong Buy
- BY Hold
- Analyst Count
- HROW 7
- BY 3
- Target Price
- HROW $68.50
- BY $33.67
- AVG Volume (30 Days)
- HROW 558.8K
- BY 182.9K
- Earning Date
- HROW 11-10-2025
- BY 10-23-2025
- Dividend Yield
- HROW N/A
- BY 1.47%
- EPS Growth
- HROW N/A
- BY 1.86
- EPS
- HROW N/A
- BY 2.81
- Revenue
- HROW $227,661,000.00
- BY $400,663,000.00
- Revenue This Year
- HROW $43.92
- BY $18.69
- Revenue Next Year
- HROW $41.22
- BY $3.10
- P/E Ratio
- HROW N/A
- BY $9.67
- Revenue Growth
- HROW 47.69
- BY 7.23
- 52 Week Low
- HROW $20.85
- BY $22.63
- 52 Week High
- HROW $54.19
- BY $32.89
- Technical
- Relative Strength Index (RSI)
- HROW 31.53
- BY 50.17
- Support Level
- HROW $36.20
- BY $26.43
- Resistance Level
- HROW $38.52
- BY $27.43
- Average True Range (ATR)
- HROW 1.65
- BY 0.57
- MACD
- HROW -0.43
- BY 0.05
- Stochastic Oscillator
- HROW 10.74
- BY 40.30
About HROW Harrow Inc.
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.
About BY Byline Bancorp Inc.
Byline Bancorp Inc is the holding company for Byline Bank, a full-service commercial bank serving small-and-medium sized businesses, financial sponsors, and consumers. The company offers a broad range of banking products and services to small and medium sized businesses, commercial real estate and online account opening to consumer and business. Also provide trust and wealth management services to its customers. In addition to traditional commercial banking business, company provide small ticket equipment leasing solutions through Byline Financial Group, a wholly-owned subsidiary of Byline Bank.